Purpose: AF is also common among hemodialysis patients and is associated with high mortality. P wave dispersion have been shown to be a predictor of AF in several clinical conditions. The objective of our study was to determine the effects of dialysis on P wave dispersion and P wave durations among non diabetic patients with end-stage renal disease on chronic hemodialysis.
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INTRODUCTION
Atrial fibrillation (AF) is a highly prevalent (13%) arrhythmia in patients with chronic renal insufficiency on hemodialysis. History of congestive heart failure, valvular heart disease, left atrial enlargement, systemic hypertension and advanced age are independently associated with AF. The conditions mentioned above are frequent among end stage kidney disease patients especially receving hemodialysis (1). P wave dispersion (PWD) is defined as the difference between the maximum and minimum P wave durations. PWD is an electrocardiographic parameter that reflects inhomogenous and discontinious atrial conduction of sinus impulses (2, 3) . Prolonged P wave duration and increased PWD have been reported to be associated with an increased risk for AF (4, 5, 6) . The response of P wave duration and PWD to hemodialysis may be variable and mediated by an interplay of electrolytic shifts and electrophysioloic and extracardiac mechanisms associated with the alleviation of fluid overload (7).
The purpose of our study was to evaluate the effects of hemodialysis on P wave durations and P wave dispersion.
PATIENTS AND METHODS
Eigthy-seven non-diabetic patients ( 43 males and 44 females , mean age 49.65±15.7 ) with end-stage kidney disease on hemodialysis treatment were selected. The study population had no impulse generation or conduction defect or previous episode of AF. All patients were in sinus rhythm during the study. Exclusion criteria were; current atrial fibrillation, no P wave on ECG or no clear point of return to the isoelectric line. The underlying causes for chronic renal failure were chronic glomerulonephritis (n=37) , hypertensive nephrosclerosis (n=7), amiloidosis ( n=2) , polycystic kidney disease (n=5), obstructive nephropathy (n=3) and unknown etiology ( n=33 (8) . All subjects underwent a conventional 12-lead ECG examination immediately before the hemodialysis session and at the end within 20 minutes. Simultaneous 12-lead ECGs were recorded by means of 12-channel ECG equipment (Hewlett Packard Page Writer 200i; M1071A, China), at a paper speed of 25 mm/s. On every occasion, the ECG was obtained in a comfortable supine position. During ECG recordings, all patients breathed freely and did not speak. ECG electrodes were not changed or renewed during or after haemodialysis. For measurement of P wave duration, the 12-lead ECG printouts were enlarged on the same photocopier by a factor of three. P wave duration was measured with calipers in all 12 leads by one observer in order to exclude interobserver variability. P wave duration was measured from the first electrical activity to the offset at the junction between the end of P wave deflection and the isoelectric line. P wave dispersion was defined as the difference between the maximum and minimum value of P wave duration. Three consecutive cardiac cycles were measured and averaged.
The study was approved by the local ethics committee and all participants gave informed consent.
STATISTICAL ANALYSIS
All statistical analysis were performed by SPSS 15.0 for Windows (Chicago, IL, USA ). All data were expressed as mean ±SD. Statistical analysis was carried out using a paired Student's t test for continous variables.
A P value <0.05 was considered statistically significant. Spearman's correlation test was used to explore correlation with P dispersion and clinical characteristics and electrolytes
RESULTS
Clinical and demographic variables have been shown Table 1 . (Fig. 1) .
Durig hemodialysis serum potassium, calcium and phosphate levels decreased significantly.
According to Spearman's correlation analysis P dispersion after dialysis was significantly correlated with post dialysis calcium concentration (r=0.24, p=0.02) and inversely correlated with left atrium diameter ( r = -0.24 , p =0.02). P dispersion after hemodialysis did not correlate significantly with age, duration of hemodialysis, serum potassium levels, left ventricular ejection fraction. Predialysis P dispersion did not correlate significantly with any parameter.
DISCUSSION
AF is a common arrhythmia among end stage renal disease patients undergoing hemodialysis program. Prolonged P wave duration and increased P dispersion have been reported to be associated with an increased risk for AF in various clinical settings (9, 10) . PWD increases significantly during hemodialysis sessions. This may increase the risk of AF episodes during hemodialysis (11) .
In our study we have demonstrated nonsignificant differance in P wave maximum duration, P wave minimum duration and P wave dispersion after hemodialysis sessions compared to the predialysis period. AF is more prevalant among hemodialysis patients compared to peritoneal dialysis patients and majortiy of arrhythmia episodes occur during hemodialysis sessions (11, 12) . In the light of these facts investigators performed several studies to find out simple electrocardiographic markers to predict atrial fibrillation among end stage renal disease patients.
There are several studies exploring the effects of hemodialysis on P wave duration and P wave dispersion but results are controversial and sample sizes are small. Szabo et al. (13) investigated the effect of hemodialysis on P wave dispersion in twenty -eight nondiabetic patients and reported that P wave dispersion increased after hemodialysis. However when they subgrouped the patients they noticed that increase in P dispersion was only observed among patients with enlarged left atrium (>45 mm ). Compared to Szabo's study group our patients had smaller left arium diameter (38.7±0.5 mm vs 44.1±6.9 mm ). Ischemic heart disease was also more prevelant in Szabo's group compared to our patients ( 64 % vs 10%). Tezcan et al. (14) studied thirthy-two hemodialysis patients and reported increased P wave dispersion and maxiumum P wave duration after hemodialysis. Hypertension prevalance was higher compared to our group among Tezcan' s patients (52% vs 31 %). In the other study Drighil et al. (15) reported that P dispersion and P wave durations were stable in their study. Ozben et al. (16) reported that increase in P wave durations and P disperion returns back to the predialysis values after hemodialysis session. Similar to latter two studies we did not find any significant difference between P wave dispersion and P wave durations before and after hemodialysis. Likewise P wave measurements, baseline characteristics of our patients were similar with Drighil and Ozben's groups. Significant increase in P dispersion among Tezcan and Szabo's groups may be releated to the higher rate of hypertensive and ischemic heart disease patients. Different results from mentioned above studies may be releated to the very different baseline clinical and demographic characteristics of study groups. Increase in P dispersion and P durations during electrolyte imbalance course especially hypocalemic period among hypertensive, diabetic or CAD patients will not be a surprising finding . So such studies cannot be used for general dialysis population.
Despite lack of significant change during hemodialysis in PWD and P dispersion, long term follow up studies should be performed to determine the predictive values of these parameters on AF among hemodialysis patients.
